SEC 13F Intelligence

Endurant Capital Management LP / IART

Endurant Capital Management LP’s Integra Lifesciences Hldgs C Position

Does Endurant Capital Management LP own Integra Lifesciences Hldgs C (IART)? Not currently — the last reported position was 281.6K shares worth $13M in Q3 2020; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$13M
Q3 2020
Shares
281.6K
% of Portfolio
+3.93%
Quarters Held
3
position exited

Position History IART

Reported value by quarter
Q2 ’19: $2MQ2 ’19Q3 ’19: $5MQ3 ’19Q3 ’20: $13MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020281.6K$13M+3.93%
Q3 201984.2K$5M+1.82%
Q2 201942.8K$2M+0.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of IART.